Bayer Loses CTM Opposition

012351458aspirinOn 29 October 2015, OHIM’s Opposition Division of the Office dismissed Bayer’s opposition against registration of the mark SALOSPIR & Design (No. 012351458).

Bayer opposed Uni-Pharma SA’s application for the mark SALOSPIR & Design for pharmaceutical preparations in Class 5 based on three prior national registrations of ASPIRIN (with and without designs).

In dismissing the opposition, the Opposition Division, assuming that the earlier marks have a reputation for pharmaceuticals and related products, found that, although the marks are similar to a certain extent (in particular taking into account that they all include the letters “S-P-I-R”), they had significant differences and, because of these differences, the public was unlikely to make a mental connection between the marks in dispute. In particular, the Opposition Division stressed that the marks differed in their initial letters, on which consumers tend to focus, and also in their figurative elements.

Further, these colors in the marks are of limited distinctiveness because they are either functional (white) or commonly used in the relevant field (green), so that they have extremely low distinctive character in connection with pharmaceuticals and, therefore, no likelihood of confusion or dilution could be established.


This entry was posted in Pharmaceutical Trademarks, Trademark Infringement, Trademarks, Uncategorized and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s